Federated Hermes’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-56,417
Closed -$13.9M 2327
2022
Q3
$13.9M Buy
56,417
+15,499
+38% +$4.19M 0.04% 455
2022
Q2
$10.1M Sell
40,918
-3,031
-7% -$818K 0.03% 541
2022
Q1
$14.6M Sell
43,949
-19,590
-31% -$6.03M 0.03% 521
2021
Q4
$22.8M Buy
63,539
+1,964
+3% +$664K 0.04% 463
2021
Q3
$20M Sell
61,575
-944
-2% -$320K 0.04% 470
2021
Q2
$19.5M Sell
62,519
-8,803
-12% -$2.7M 0.04% 491
2021
Q1
$22.7M Sell
71,322
-28,691
-29% -$9.18M 0.04% 458
2020
Q4
$32.4M Buy
100,013
+3,596
+4% +$995K 0.07% 339
2020
Q3
$26.7M Sell
96,417
-42,793
-31% -$12.3M 0.06% 349
2020
Q2
$33.6M Sell
139,210
-31,599
-18% -$6.34M 0.08% 280
2020
Q1
$24.8M Buy
170,809
+10,936
+7% +$1.82M 0.07% 295
2019
Q4
$27.3M Buy
159,873
+46,866
+41% +$8.69M 0.06% 331
2019
Q3
$20.1M Buy
113,007
+12,185
+12% +$2.63M 0.05% 370
2019
Q2
$26.3M Buy
100,822
+55,453
+122% +$14.7M 0.06% 300
2019
Q1
$13M Sell
45,369
-6,846
-13% -$2.28M 0.03% 471
2018
Q4
$17M Sell
52,215
-9,237
-15% -$3.21M 0.05% 347
2018
Q3
$27.6M Buy
61,452
+1,669
+3% +$658K 0.06% 287
2018
Q2
$24.5M Sell
59,783
-20,980
-26% -$7.6M 0.07% 219
2018
Q1
$23.5M Buy
80,763
+12,927
+19% +$3.28M 0.07% 220
2017
Q4
$12.7M Buy
67,836
+2,824
+4% +$527K 0.04% 374
2017
Q3
$11M Buy
65,012
+36,268
+126% +$5.48M 0.03% 382
2017
Q2
$4.12M Sell
28,744
-5,700
-17% -$766K 0.01% 643
2017
Q1
$4.31M Buy
34,444
+3,095
+10% +$359K 0.01% 635
2016
Q4
$3.53M Sell
31,349
-98,392
-76% -$11.4M 0.01% 665
2016
Q3
$16.7M Buy
129,741
+97,256
+299% +$11.6M 0.05% 300
2016
Q2
$3.55M Sell
32,485
-21,604
-40% -$2.15M 0.01% 652
2016
Q1
$5.13M Buy
54,089
+31,358
+138% +$2.65M 0.02% 542
2015
Q4
$2.05M Sell
22,731
-15,153
-40% -$1.29M 0.01% 864
2015
Q3
$3.51M Buy
37,884
+3,781
+11% +$333K 0.01% 673
2015
Q2
$2.24M Buy
34,103
+9,359
+38% +$622K 0.01% 893
2015
Q1
$1.77M Buy
+24,744
New +$1.34M 0.01% 1006

Other funds holding ABMD